GALAPAGOS
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.
GALAPAGOS
Industry:
Biopharma Biotechnology Clinical Trials Health Care Medical
Founded:
1999-01-01
Address:
Mechelen-bovelingen, Limburg, Belgium
Country:
Belgium
Website Url:
http://www.glpg.com
Total Employee:
251+
Status:
Active
Contact:
+32 15 34 29 00
Total Funding:
5.45 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Board_member
1999-01-01
Board_member
2013-01-01
Board_member
Current Employees Featured
Onno Stolpe CEO @ Galapagos
CEO
1999-01-01
Werner Cautreels Director @ Galapagos
Director
Andre Hoekema Chief Business Officer @ Galapagos
Chief Business Officer
Bart Filius Chief Operating Officer & Chief Financial Officer @ Galapagos
Chief Operating Officer & Chief Financial Officer
Walid Abi-Saab Chief Medical Officer @ Galapagos
Chief Medical Officer
Piet Wigerinck Chief Scientific Officer @ Galapagos
Chief Scientific Officer
Kruti Popat Director, Customer Insights & Engagement @ Galapagos
Director, Customer Insights & Engagement
Paul Passier Director Clinical Pharmacology @ Galapagos
Director Clinical Pharmacology
2018-01-01
Michele Manto Chief Commercial Officer @ Galapagos
Chief Commercial Officer
2020-01-01
Philip Vyt Senior Director Global Omnichannel Capabilities & Digital Innovation @ Galapagos
Senior Director Global Omnichannel Capabilities & Digital Innovation
2020-10-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-21 | CellPoint | CellPoint acquired by Galapagos | 125 M EUR |
| 2021-06-21 | Abound Bio | Abound Bio acquired by Galapagos | 14 M USD |
| 2013-01-15 | Cangenix | Cangenix acquired by Galapagos | N/A |
| 2010-02-02 | Argenta Discovery | Argenta Discovery acquired by Galapagos | N/A |
| 2007-01-02 | ProStrakan | ProStrakan acquired by Galapagos | 31 M EUR |
| 2006-12-07 | Inpharmatica | Inpharmatica acquired by Galapagos | 19.1 M EUR |
| 2005-09-21 | BioFocus DPI | BioFocus DPI acquired by Galapagos | 36.5 M USD |
Investors List
Gilead Sciences
Gilead Sciences investment in Post-IPO Equity - Galapagos
University of Antwerp
University of Antwerp investment in Grant - Galapagos
Van Herk Ventures
Van Herk Ventures investment in Post-IPO Equity - Galapagos
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos
Thuja Capital
Thuja Capital investment in Venture Round - Galapagos
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos
The Institute for the Promotion of Innovation by Science and Technology in Flanders
The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos
Gilde Healthcare
Gilde Healthcare investment in Venture Round - Galapagos
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2013-07-01 | Vitalnext | Galapagos investment in Funding Round - Vitalnext | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-26 | Galapagos appoints Paul Stoffels as Chief Executive Officer |
Official Site Inspections
http://www.glpg.com Semrush global rank: 39.37 K Semrush visits lastest month: 3.28 M
- Host name: s3-website-eu-west-1.amazonaws.com
- IP address: 52.218.110.92
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Galapagos"
Our Vision and Mission - Galapagos NV Annual Report 2024
Risks Related to Our Organization, Structure and Operation; Market Risks Relating to the Galapagos Shares; General Statement about Galapagos’ Risks; Financial Statements. …See details»
Galapagos - Pioneering for patients
Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from …See details»
Board of Directors - Galapagos NV Annual Report 2024
Dec 31, 2024 Risks Related to Our Organization, Structure and Operation; Market Risks Relating to the Galapagos Shares; General Statement about Galapagos’ Risks; Financial …See details»
Galapagos Publishes 2024 Annual Report and Announces Annual ...
21 hours ago Mechelen, Belgium; March 27, 2025, 21:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today publishes its annual report for the …See details»
Collaborations - Galapagos - glpg.com
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Galapagos and …See details»
Galapagos : Annual Report 2024 1 | MarketScreener
4 hours ago TAABBOLAUETTOATFGHCLISOANRNECTPEONRTTS 2024 Financial Highlights ATabboluetotfhCisoRnetpenotrst ...See details»
SEC.gov
00014218762024FYfalse2024-12-31falseInternational Financial Reporting Standardstruetruetruetruefalsetruetrue0.250 ...See details»
Organization, structure and operation - Galapagos Annual Report …
Organization, structure and operation. CSR report. Galapagos NV • Annual Report 2020. Our future success depends on our ability to retain the members of our management board and to …See details»
五星体育 to Unlock Shareholder Value by Declaring its Intent to …
MECHELEN, Belgium 鈥?January 8, 2025 鈥?07:30 CET; regulated information 鈥?inside information 鈥?五星体育 NV (Euronext & NASDAQ: GLPG) (鈥溛逍翘逵 €?or the 鈥淐ompany …See details»
Intended Separation - Galapagos - glpg.com
Galapagos Executing a Focused Cell Therapy Vision in Oncology. Galapagos will focus on unlocking the broad potential of its decentralized cell therapy manufacturing platform in …See details»
Galapagos : GLPG Convening Notice ENG FINAL | MarketScreener
4 hours ago The notice must reach the Company by e-mail at shareholders@glpg.com or by mail at its registered office (Generaal De Wittelaan L11 A3, 2800 Mechelen ... The processing …See details»
About Us - GLP
As a leading global investment manager and business builder in logistics, real estate, infrastructure, finance and related technologies we are deeply invested in businesses that …See details»
永利娱乐场 Expands Galapagos鈥?Decentralized CAR-T …
Jan 21, 2025 永利娱乐场 & Galapagos partner to support Galapagos鈥?investigational CAR-T therapy for relapsed/refractory non-Hodgkin lymphoma indications.See details»
Galapagos announces full year 2023 results and outlook for 2024
Dec 31, 2023 Webcast presentation tomorrow, 23 February 2024, at 14:00 CET / 8:00 am ET, www.glpg.com. Mechelen, Belgium; 22 February 2024, 22:01 CET; regulated information – …See details»
Our Culture | GLP
The diversity of our workforce is visible at every level of the organization and in every business area. In essence, having people from diverse backgrounds, experiences, perspectives, and …See details»
Organization | Consumer Packaged Goods | McKinsey & Company
Consumer organization database: Proprietary database of headcount benchmarks that allows for comprehensive and consistent analysis across all functions of a consumer-goods company. …See details»
Galapagos Reports Full Year 2024 Results and Provides Fourth …
Mechelen, Belgium; February 12, 2025, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG), a global biotechnology company dedicated to transforming …See details»
Privacy Notice for Health Care Professionals - 五星体育
Relationship Management: – know and understand the professional history and professional qualification; – build your profile and get a better understanding of your expertise and topics of …See details»
Newsroom - Galapagos
Feb 24, 2025 Newsroom. Extra! Extra! Read all about it. Welcome to our Newsroom, your go-to source for the latest updates on Galapagos. Explore press releases, insightful blogs, and …See details»